https://www.selleckchem.com/products/MLN8237.html
Much attention has been paid to the study and reporting of gastrointestinal (GI) symptoms in COVID-19 patients. Moreover, an increasing number of COVID-19 patients have been noted to experience hepatic and pancreatic injury. In this study, we retrospectively investigated symptoms and laboratory findings related to the GI system in a single center in Athens, Greece, and assessed the role of these parameters in relation to survival and disease severity. We retrospectively studied 61 adult COVID-19 patients admitted to the Army Share Fund
Like
Comment
Share
